Skip to main content
Top
Published in: Clinical Rheumatology 8/2016

Open Access 01-08-2016 | Original Article

Knowledge, illness perceptions and stated clinical practice behaviour in management of gout: a mixed methods study in general practice

Authors: Bart Spaetgens, Tobias Pustjens, Lieke E. J. M. Scheepers, Hein J. E. M. Janssens, Sjef van der Linden, Annelies Boonen

Published in: Clinical Rheumatology | Issue 8/2016

Login to get access

Abstract

The objective of the present study is to explore knowledge, illness perceptions and stated practice behaviour in relation to gout in primary care. This is a mixed methods study among 32 general practitioners (GPs). The quantitative assessment included the Gout Knowledge Questionnaire (GKQ; range 0–10; better) and Brief Illness Perceptions Questionnaire (BIPQ; nine items, range 0–10; stronger). Structured individual interviews obtained further qualitative insight into knowledge and perceptions, in the context of daily practice. Among 32 GPs, 18 (56.3 %) were male, mean age 44.4 years (SD 9.6) and mean working experience 17.1 years (SD 9.7). Median score [interquartile ranges (IQR)] on the GKQ was 7.8 [6.7–8.9] and 9.0 [8.0–10.0], when presented as open or multiple-choice questions, respectively. The BIPQ (median; [IQR]) revealed that gout was seen as a chronic disease (8.0; [7.0–9.0]), affecting life and emotions moderately (6.5; [5.0–7.0]), having many severe symptoms (8.0; [7.0–9.0]) and in which treatment could be very helpful (8.0; [7.0–9.0]). Further interviews revealed large variation in specific aspects of knowledge and about gaps concerning indications for uric acid-lowering therapy (UALT), duration of UALT, target serum uric acid (sUA) level or duration of prophylactic treatment. Finally, patients’ adherence was not checked systematically. Specific knowledge gaps and discrepancies between perceptions and stated practice behaviour were identified, which might hamper effective management of this well-treatable disease. Improving evidence on the rationale and effectiveness of treatment targets and adherence interventions, tailoring guidelines to general practice and intensification of implementation of guidelines in primary health care seem to be needed.
Literature
1.
go back to reference Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M (2015) Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis 74:661–667CrossRefPubMed Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M (2015) Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis 74:661–667CrossRefPubMed
2.
go back to reference Zhu Y, Pandya BJ, Choi HK (2011) Prevalence of gout and hyperuricaemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum 63:3136–3141CrossRefPubMed Zhu Y, Pandya BJ, Choi HK (2011) Prevalence of gout and hyperuricaemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum 63:3136–3141CrossRefPubMed
3.
go back to reference Wijnands JM, Viechtbauer W, Thevissen K, Arts IC, Dagnelie PC, Stehouwer CD, van der Linden S, Boonen A (2015) Determinants of the prevalence of gout in the general population: a systematic review and meta-regression. Eur J Epidemiol 30:19–33CrossRefPubMed Wijnands JM, Viechtbauer W, Thevissen K, Arts IC, Dagnelie PC, Stehouwer CD, van der Linden S, Boonen A (2015) Determinants of the prevalence of gout in the general population: a systematic review and meta-regression. Eur J Epidemiol 30:19–33CrossRefPubMed
4.
go back to reference Jeyaruban A, Larkins S, Soden M (2015) Management of gout in general practice—a systematic review. Clin Rheumatol 34:9–16CrossRefPubMed Jeyaruban A, Larkins S, Soden M (2015) Management of gout in general practice—a systematic review. Clin Rheumatol 34:9–16CrossRefPubMed
5.
go back to reference Oderda GM, Shiozawa A, Walsh M, Hess K, Brixner DI, Feehan M, Akhras K (2014) Physician adherence to ACR gout treatment guidelines: perception versus practice. Postgrad Med 126:257–267CrossRefPubMed Oderda GM, Shiozawa A, Walsh M, Hess K, Brixner DI, Feehan M, Akhras K (2014) Physician adherence to ACR gout treatment guidelines: perception versus practice. Postgrad Med 126:257–267CrossRefPubMed
6.
go back to reference Robinson PC, Taylor WJ, Dalbeth N (2015) An observational study of gout prevalence and quality of care in a national Australian general practice population. J Rheumatol 42:1702–1707CrossRefPubMed Robinson PC, Taylor WJ, Dalbeth N (2015) An observational study of gout prevalence and quality of care in a national Australian general practice population. J Rheumatol 42:1702–1707CrossRefPubMed
7.
go back to reference De Vera MA, Marcotte G, Rai S, Galo JS, Bhole V (2014) Medication adherence in gout: a systematic review. Arthritis Care Res (Hoboken) 66:1551–1559CrossRef De Vera MA, Marcotte G, Rai S, Galo JS, Bhole V (2014) Medication adherence in gout: a systematic review. Arthritis Care Res (Hoboken) 66:1551–1559CrossRef
8.
go back to reference Doherty M, Jansen TL, Nuki G, Pascual E, Perez-Ruiz F, Punzi L, So AK, Bardin T (2012) Gout: why is this curable disease so seldom cured? Ann Rheum Dis 71:1765–1770CrossRefPubMed Doherty M, Jansen TL, Nuki G, Pascual E, Perez-Ruiz F, Punzi L, So AK, Bardin T (2012) Gout: why is this curable disease so seldom cured? Ann Rheum Dis 71:1765–1770CrossRefPubMed
9.
go back to reference Johnston ME, Treharne GJ, Chapman PT, Stamp LK (2015) Patient information about gout: an international review of existing educational resources. J Rheumatol 42:975–978CrossRefPubMed Johnston ME, Treharne GJ, Chapman PT, Stamp LK (2015) Patient information about gout: an international review of existing educational resources. J Rheumatol 42:975–978CrossRefPubMed
10.
go back to reference Stamp LK, Merriman TR, Barclay ML, Singh JA, Roberts RL, Wright DF, Dalbeth N (2014) Impaired response or insufficient dosage? Examining the potential causes of “inadequate response” to allopurinol in the treatment of gout. Semin Arthritis Rheum 44:170–174CrossRefPubMedPubMedCentral Stamp LK, Merriman TR, Barclay ML, Singh JA, Roberts RL, Wright DF, Dalbeth N (2014) Impaired response or insufficient dosage? Examining the potential causes of “inadequate response” to allopurinol in the treatment of gout. Semin Arthritis Rheum 44:170–174CrossRefPubMedPubMedCentral
11.
go back to reference Ogdie AR, Hoch S, Dunham J, Von Feldt JM (2010) A roadmap for education to improve the quality of care in gout. Curr Opin Rheumatol 22:173–180CrossRefPubMed Ogdie AR, Hoch S, Dunham J, Von Feldt JM (2010) A roadmap for education to improve the quality of care in gout. Curr Opin Rheumatol 22:173–180CrossRefPubMed
13.
go back to reference van Onna M, Hinsenveld E, de Vries H, Boonen A (2015) Health literacy in patients dealing with gout: a qualitative study. Clin Rheumatol 34:1599–1603CrossRefPubMed van Onna M, Hinsenveld E, de Vries H, Boonen A (2015) Health literacy in patients dealing with gout: a qualitative study. Clin Rheumatol 34:1599–1603CrossRefPubMed
14.
15.
go back to reference Spencer K, Carr A, Doherty M (2012) Patient and provider barriers to effective management of gout in general practice: a qualitative study. Ann Rheum Dis 71:1490–1495CrossRefPubMed Spencer K, Carr A, Doherty M (2012) Patient and provider barriers to effective management of gout in general practice: a qualitative study. Ann Rheum Dis 71:1490–1495CrossRefPubMed
17.
go back to reference O’Cathain A, Murphy E, Nicholl J (2008) The quality of mixed methods studies in health services research. J Health Serv Res Policy 13:92–98CrossRefPubMed O’Cathain A, Murphy E, Nicholl J (2008) The quality of mixed methods studies in health services research. J Health Serv Res Policy 13:92–98CrossRefPubMed
19.
go back to reference Zhang LY, Schumacher HR, Su HH, Lie D, Dinnella J, Baker JF, Von Feldt JM (2011) Development and evaluation of a survey of gout patients concerning their knowledge about gout. J Clin Rheumatol 17:242–248CrossRefPubMed Zhang LY, Schumacher HR, Su HH, Lie D, Dinnella J, Baker JF, Von Feldt JM (2011) Development and evaluation of a survey of gout patients concerning their knowledge about gout. J Clin Rheumatol 17:242–248CrossRefPubMed
20.
go back to reference Li QH, Dai L, Li ZX, Liu HJ, Zou CJ, Ou-Yang X, Lu M, Li T, Li YH, Mo YQ et al (2013) Questionnaire survey evaluating disease-related knowledge for 149 primary gout patients and 184 doctors in South China. Clin Rheumatol 32:1633–1640CrossRefPubMed Li QH, Dai L, Li ZX, Liu HJ, Zou CJ, Ou-Yang X, Lu M, Li T, Li YH, Mo YQ et al (2013) Questionnaire survey evaluating disease-related knowledge for 149 primary gout patients and 184 doctors in South China. Clin Rheumatol 32:1633–1640CrossRefPubMed
21.
go back to reference Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P et al (2005) Principles of good practice for the translation and cultural adaptation process for Patient-Reported Outcomes (PRO) measures: report of the ISPOR Task Force for translation and cultural adaptation. Value Health 8:94–104CrossRefPubMed Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P et al (2005) Principles of good practice for the translation and cultural adaptation process for Patient-Reported Outcomes (PRO) measures: report of the ISPOR Task Force for translation and cultural adaptation. Value Health 8:94–104CrossRefPubMed
22.
go back to reference Beaton DE, Bombardier C, Guillemin F, Ferraz MB (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 25:3186–3191CrossRef Beaton DE, Bombardier C, Guillemin F, Ferraz MB (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 25:3186–3191CrossRef
23.
go back to reference Broadbent E, Petrie KJ, Main J, Weinman J (2006) The brief illness perception questionnaire. J Psychosom Res 60:631–637CrossRefPubMed Broadbent E, Petrie KJ, Main J, Weinman J (2006) The brief illness perception questionnaire. J Psychosom Res 60:631–637CrossRefPubMed
24.
go back to reference de Raaij EJ, Schroder C, Maissan FJ, Pool JJ, Wittink H (2012) Cross-cultural adaptation and measurement properties of the Brief Illness Perception Questionnaire-Dutch Language Version. Man Ther 17:330–335CrossRefPubMed de Raaij EJ, Schroder C, Maissan FJ, Pool JJ, Wittink H (2012) Cross-cultural adaptation and measurement properties of the Brief Illness Perception Questionnaire-Dutch Language Version. Man Ther 17:330–335CrossRefPubMed
25.
go back to reference Pope C, Mays N (2006) Qualitative research in health care, 3rd edn. Malden, Mass.: Blackwell Pub./BMJ Books Pope C, Mays N (2006) Qualitative research in health care, 3rd edn. Malden, Mass.: Blackwell Pub./BMJ Books
26.
go back to reference Rashid N, Coburn BW, Wu YL, Cheetham TC, Curtis JR, Saag KG, Mikuls TR (2015) Modifiable factors associated with allopurinol adherence and outcomes among patients with gout in an integrated healthcare system. J Rheumatol 42:504–512CrossRefPubMed Rashid N, Coburn BW, Wu YL, Cheetham TC, Curtis JR, Saag KG, Mikuls TR (2015) Modifiable factors associated with allopurinol adherence and outcomes among patients with gout in an integrated healthcare system. J Rheumatol 42:504–512CrossRefPubMed
27.
go back to reference George M, Pullman-Mooar S, Hussain F, Schumacher HR (2014) Evaluating appropriate use of prophylactic colchicine for gout flare prevention. Arthritis Care Res (Hoboken) 66:1258–1262CrossRef George M, Pullman-Mooar S, Hussain F, Schumacher HR (2014) Evaluating appropriate use of prophylactic colchicine for gout flare prevention. Arthritis Care Res (Hoboken) 66:1258–1262CrossRef
28.
go back to reference Moi JH, Sriranganathan MK, Falzon L, Edwards CJ, van der Heijde DM, Buchbinder R (2014) Lifestyle interventions for the treatment of gout: a summary of 2 Cochrane systematic reviews. J Rheumatol Suppl 92:26–32CrossRefPubMed Moi JH, Sriranganathan MK, Falzon L, Edwards CJ, van der Heijde DM, Buchbinder R (2014) Lifestyle interventions for the treatment of gout: a summary of 2 Cochrane systematic reviews. J Rheumatol Suppl 92:26–32CrossRefPubMed
29.
go back to reference Dalbeth N, Petrie KJ, House M, Chong J, Leung W, Chegudi R, Horne A, Gamble G, McQueen FM, Taylor WJ (2011) Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability. Arthritis Care Res (Hoboken) 63(11):1605–1612CrossRef Dalbeth N, Petrie KJ, House M, Chong J, Leung W, Chegudi R, Horne A, Gamble G, McQueen FM, Taylor WJ (2011) Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability. Arthritis Care Res (Hoboken) 63(11):1605–1612CrossRef
30.
go back to reference Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, Gerster J, Jacobs J, Leeb B, Liote F et al (2006) EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1312–1324CrossRefPubMedPubMedCentral Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, Gerster J, Jacobs J, Leeb B, Liote F et al (2006) EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1312–1324CrossRefPubMedPubMedCentral
31.
go back to reference Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S et al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricaemia. Arthritis Care Res (Hoboken) 64:1431–1446CrossRef Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S et al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricaemia. Arthritis Care Res (Hoboken) 64:1431–1446CrossRef
32.
go back to reference Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S et al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) 64:1447–1461CrossRef Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S et al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) 64:1447–1461CrossRef
33.
go back to reference Mikuls TR, MacLean CH, Olivieri J, Patino F, Allison JJ, Farrar JT, Bilker WB, Saag KG (2004) Quality of care indicators for gout management. Arthritis Rheum 50:937–943CrossRefPubMed Mikuls TR, MacLean CH, Olivieri J, Patino F, Allison JJ, Farrar JT, Bilker WB, Saag KG (2004) Quality of care indicators for gout management. Arthritis Rheum 50:937–943CrossRefPubMed
34.
go back to reference Janssens HJLH, Van Peet PG, Gorter KJ, Van der Pas P, Van der Paardt M, Woutersen-Koch H (2009) NHG Standaard Artritis. Huisarts Wet 52:439–453CrossRef Janssens HJLH, Van Peet PG, Gorter KJ, Van der Pas P, Van der Paardt M, Woutersen-Koch H (2009) NHG Standaard Artritis. Huisarts Wet 52:439–453CrossRef
35.
go back to reference Harrold LR, Mazor KM, Negron A, Ogarek J, Firneno C, Yood RA (2013) Primary care providers’ knowledge, beliefs and treatment practices for gout: results of a physician questionnaire. Rheumatology (Oxford) 52:1623–1629CrossRef Harrold LR, Mazor KM, Negron A, Ogarek J, Firneno C, Yood RA (2013) Primary care providers’ knowledge, beliefs and treatment practices for gout: results of a physician questionnaire. Rheumatology (Oxford) 52:1623–1629CrossRef
Metadata
Title
Knowledge, illness perceptions and stated clinical practice behaviour in management of gout: a mixed methods study in general practice
Authors
Bart Spaetgens
Tobias Pustjens
Lieke E. J. M. Scheepers
Hein J. E. M. Janssens
Sjef van der Linden
Annelies Boonen
Publication date
01-08-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 8/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3212-2

Other articles of this Issue 8/2016

Clinical Rheumatology 8/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.